Acuitas Investments, LLC Harrow Health, Inc. Transaction History

Acuitas Investments, LLC

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 06, 2023	SELL	$10.28 - $14.78 $1.02 Million - $1.47 Million	-99,708 Reduced 29.5%	238,241 $3.52 Million
Q3 2022 Nov 02, 2022	BUY	$6.57 - $24.88 $291,655 - $1.1 Million	44,392 Added 15.12%	337,949 $4.08 Million
Q2 2022 Aug 03, 2022	BUY	$5.75 - $7.74 $1.69 Million - $2.27 Million	293,557 New	293,557 $2.14 Million

177

21.4M

845K

717K

Ticker HROW
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 27,070,000
Market Cap $992M
Description
Harrow Health, Inc. operates as an ophthalmic-focused healthcare company. The company owns ImprimisRx, an ophthalmology outsourcing and pharmaceutical compounding business; and DEXYCU for the treatment of post-operative inflammation. The company also holds equity interests in Surface Ophthalmics, Inc., a clinical-stage pharmaceutical company tha...

Get notified when there are updates to the investment portfolio of Acuitas Investments, LLC, based on Form 13F filings with the SEC.

Stay updated on Acuitas Investments, LLC with notifications on news.